Exposure and toxicity studies comparing menthol and nonmenthol cigarettes have resulted in mixed results. On the basis of those results, cigarette manufacturers have concluded that there is no increased harm from the addition of menthol to cigarettes. We propose that such a narrow definition of harm is not appropriate in dealing with the issue of menthol, and its broader negative public health impact. Cancer Epidemiol Biomarkers Prev; 20(7); 1269–71. ©2011 AACR.

Commentary on Caraballo et al., p. 1329

In this issue, Caraballo and colleagues add to the growing body of literature concerning the biomarkers of toxicity of menthol added to cigarettes (1). Even laboratory-based exposure studies (carbon monoxide, cotinine) have had mixed results, with some studies reporting decreased values, some increased, and some no difference when menthol cigarettes (compared with nonmenthol cigarettes) are smoked (2–9). These results, and the generally null results reported following examination for increased toxicity of menthol cigarettes (10–20) are understandable for 2 reasons. First, all previous studies (both epidemiologic and laboratory-based) that have attempted to determine whether mentholation of cigarettes produces additional harm have utilized commercial menthol and nonmenthol brands. Those studies have been obfuscated by the many other ways that commercial cigarettes differ other than just menthol concentration. For policy makers to judge whether mentholation itself results in additional abuse liability or toxicity, we must be able to separate the effects of menthol from other cigarette features, such as physical characteristics and available nicotine, among others. There may also be significant misclassification of cigarette type, given that most cigarettes contain some menthol at subliminal levels (21). Second, smoking causes such overwhelming harm that epidemiologic tools are unlikely to uncover additional toxicity from the addition of menthol to cigarettes. The available evidence is insufficient to definitively conclude that the addition of menthol to cigarettes increases the intake of tobacco smoke or the toxicity of that smoke. Continuing to focus on chemical or molecular nature of menthol, however, or even on menthol toxicity alone, will distract the scientific community, tobacco control professionals, and the public from the real harm associated with menthol in cigarettes.

Adding menthol to cigarettes is not benign. To accept it as such would be to very narrowly define the concept of public health harm. Rather the harm of menthol is in its masking of the harshness of tobacco smoke (22–24), its use in starter products for children (25–28), its interference with quitting and staying quit (29–36), and the deliberate targeting of menthol cigarettes to vulnerable populations (25, 37, 38). Menthol cigarettes are disproportionately target marketed to young African Americans, a particularly vulnerable segment of our society (38, 39).

Representatives of the tobacco manufacturers have been persistent in denial of the role of menthol in harming the public's health (40–42). They are only able to do so by keeping the definition of harm to a narrow focus on toxicity and disease outcomes. Recent meetings of the Tobacco Product Scientific Advisory Committee (TPSAC) of the U.S. Food and Drug Administration, with accompanying public testimony, have forced the manufacturers to confront the broader issues of harm. Unfortunately, in doing so, they have used very selective interpretation of selective literature to come to the conclusion that TPSAC, in their review of the available evidence, has produced “speculative hypotheses” that “cannot serve as the basis for regulatory policy” (43).

Any cigarette design characteristic that makes cigarettes easier to smoke, especially to the young and the naive smoker, is bad for the public health (44). Menthol masks the harshness of tobacco and provides a sensation of coolness (21), and makes low-tar cigarettes more attractive (45). The unique sensory effects of menthol, in combination with nicotine, contribute to the reinforcing effects of smoking (34).

If menthol were banned from cigarettes, at both characterizing levels (“menthol cigarettes”) and noncharacterizing levels (“nonmenthol cigarettes”), the incessant targeted advertising would come to a stop (25, 38, 44). So would the marketing with health reassurance messages and imagery (25, 39).

Other candy flavorings in cigarettes were banned on the basis of much less information than is known about the public health harm caused by mentholation of cigarettes (44). It is time to remove menthol from cigarettes and stop sweetening the poison.

No potential conflicts of interest were disclosed.

1.
Caraballo
RS
,
Holiday
DB
,
Stellman
SD
,
Mowery
PD
,
Giovino
GA
,
Muscat
JE
, et al
Comparison of serum cotinine concentrations within and across smokers of menthol and nonmenthol cigarette brands among non-Hispanic black and non-Hispanic white U.S. adult smokers, 2001–2006
.
Cancer Epidemiol Biomarkers Prev
2011
;
20
:
1329
40
.
2.
Ahijevych
K
,
Gillespie
J
,
Demirci
M
,
Jagadeesh
J
. 
Menthol and nonmenthol cigarettes and smoke exposure in black and white women
.
Pharmacol Biochem Behav
1996
;
53
:
355
60
.
3.
Ahijevych
K
,
Parsley
LA
. 
Smoke constituent exposure and stage of change in black and white women cigarette smokers
.
Addict Behav
1999
;
24
:
115
20
.
4.
Benowitz
NL
,
Herrera
B
,
Jacob
P
 III
. 
Mentholated cigarette smoking inhibits nicotine metabolism
.
J Pharmacol Exp Ther
2004
;
310
:
1208
15
.
5.
Clark
PI
,
Gautam
S
,
Gerson
LW
. 
Effect of menthol cigarettes on biochemical markers of smoke exposure among black and white smokers
.
Chest
1996
;
110
:
1194
8
.
6.
Jarvik
ME
,
Tashkin
DP
,
Caskey
NH
,
McCarthy
WJ
,
Rosenblatt
MR
. 
Mentholated cigarettes decrease puff volume of smoke and increase carbon monoxide absorption
.
Physiol Behav
1994
;
56
:
563
70
.
7.
Miller
GE
,
Jarvik
ME
,
Caskey
NH
, et al
Cigarette mentholation increases smokers' exhaled carbon monoxide levels
.
Exp Clin Psychopharmacol
1994
;
2
:
154
60
.
8.
Sellers
EM
. 
Pharmacogenetics and ethnoracial differences in smoking
.
JAMA
1998
;
280
:
179
80
.
9.
Williams
JM
,
Gandhi
KK
,
Steinberg
ML
,
Foulds
J
,
Ziedonis
DM
,
Benowitz
NL
, et al
Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia
.
Nicotine Tob Res
2007
;
9
:
873
81
.
10.
Brooks
DR
,
Palmer
JR
,
Strom
BL
,
Rosenberg
L
. 
Menthol cigarettes and risk of lung cancer
.
Am J Epidemiol
2003
;
158
:
609
16
.
11.
Carpenter
CL
,
Jarvik
ME
,
Morgenstern
H
,
McCarthy
WJ
,
London
SJ
. 
Mentholated cigarette smoking and lung-cancer risk
.
Ann Epidemiol
1999
;
9
:
114
20
.
12.
Friedman
GD
,
Sadler
M
,
Tekawa
IS
,
Sidney
S
. 
Mentholated cigarettes and non-lung smoking related cancers in California, USA
.
J Epidemiol Community Health
1998
;
52
:
202
.
13.
Hebert
JR
,
Kabat
GC
. 
Menthol cigarettes and esophageal cancer
.
Am J Public Health
1988
;
78
:
986
7
.
14.
Hebert
JR
,
Kabat
GC
. 
Menthol cigarette smoking and oesophageal cancer
.
Int J Epidemiol
1989
;
18
:
37
44
.
15.
Kabat
GC
,
Hebert
JR
. 
Use of mentholated cigarettes and lung cancer risk
.
Cancer Res
1991
;
51
:
6510
3
.
16.
Kabat
GC
,
Hebert
JR
. 
Use of mentholated cigarettes and oropharyngeal cancer
.
Epidemiology
1994
;
5
:
183
8
.
17.
Murray
RP
,
Connett
JE
,
Skeans
MA
,
Tashkin
DP
. 
Menthol cigarettes and health risks in Lung Health Study data
.
Nicotine Tob Res
2007
;
9
:
101
7
.
18.
Pletcher
MJ
,
Hulley
BJ
,
Houston
T
,
Kiefe
CI
,
Benowitz
N
,
Sidney
S
, et al
Menthol cigarettes, smoking cessation, atherosclerosis, and pulmonary function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study
.
Arch Intern Med
2006
;
166
:
1915
22
.
19.
Sidney
S
,
Tekawa
IS
,
Friedman
GD
,
Sadler
MC
,
Tashkin
DP
. 
Mentholated cigarette use and lung cancer
.
Arch Intern Med
1995
;
155
:
727
32
.
20.
Stellman
SD
,
Chen
Y
,
Muscat
JE
,
Djordjevic
MV
,
Richie
JP
,
Lazarus
P
, et al
Lung cancer risk in white and black Americans
.
Ann Epidemiol
2003
;
13
:
294
302
.
21.
Ahijevych
K
,
Garrett
BE
. 
Menthol pharmacology and its potential impact on cigarette smoking behavior
.
Nicotine Tob Res
2004
;
6
Suppl 1
:
S17
28
.
22.
Ferris
WG
,
Connolly
GN
. 
Application, function, and effects of menthol in cigarettes: a survey of tobacco industry documents
.
Nicotine Tob Res
2004
;
6
Suppl 1
:
S43
54
.
23.
Kreslake
JM
,
Wayne
GF
,
Connolly
GN
. 
The menthol smoker: tobacco industry research on consumer sensory perception of menthol cigarettes and its role in smoking behavior
.
Nicotine Tob Res
2008
;
10
:
705
15
.
24.
Kreslake
JM
,
Yerger
VB
. 
Tobacco industry knowledge of the role of menthol in chemosensory perception of tobacco smoke
.
Nicotine Tob Res
2010
;
12
Suppl 2
:
S98
101
.
25.
Healton
CG
,
Bullock
AT
,
Robinson
WS
,
Beck
SE
,
Cartwright
J
,
Eubanks
SY
, et al
Why we should make menthol cigarettes history
.
Nicotine Tob Res
2010
;
12
Suppl 2
:
S94
7
.
26.
Hersey
JC
,
Ng
SW
,
Nonnemaker
JM
,
Mowery
P
,
Thomas
KY
,
Vilsaint
MC
, et al
Are menthol cigarettes a starter product for youth?
Nicotine Tob Res
2006
;
8
:
403
13
.
27.
Hersey
JC
,
Nonnemaker
JM
,
Homsi
G
. 
Menthol cigarettes contribute to the appeal and addiction potential of smoking for youth
.
Nicotine Tob Res
2010
;
12
Suppl 2
:
S136
46
.
28.
Kreslake
JM
,
Wayne
GF
,
Alpert
HR
,
Koh
HK
,
Connolly
GN
. 
Tobacco industry control of menthol in cigarettes and targeting of adolescents and young adults
.
Am J Public Health
2008
;
98
:
1685
92
.
29.
Okuyemi
KS
,
Ahluwalia
JS
,
Ebersole-Robinson
M
,
Catley
D
,
Mayo
MS
,
Resnicow
K
, et al
Does menthol attenuate the effect of bupropion among African American smokers?
Addiction
2003
;
98
:
1387
93
.
30.
Okuyemi
KS
,
Faseru
B
,
Sanderson
CL
,
Bronars
CA
,
Ahluwalia
JS
. 
Relationship between menthol cigarettes and smoking cessation among African American light smokers
.
Addiction
2007
;
102
:
1979
86
.
31.
Okuyemi
KS
,
Ebersole-Robinson
M
,
Nazir
N
,
Ahluwalia
JS
. 
African-American menthol and nonmenthol smokers: differences in smoking and cessation experiences
.
J Natl Med Assoc
2004
;
96
:
1208
11
.
32.
Gandhi
KK
,
Foulds
J
,
Steinberg
MB
,
Lu
SE
,
Williams
JM
. 
Lower quit rates among African American and Latino menthol cigarette smokers at a tobacco treatment clinic
.
Int J Clin Pract
2009
;
63
:
360
7
.
33.
Foulds
J
,
Hooper
MW
,
Pletcher
MJ
,
Okuyemi
KS
. 
Do smokers of menthol cigarettes find it harder to quit smoking?
Nicotine Tob Res
2010
;
12
Suppl 2
:
S102
9
.
34.
Ahijevych
K
,
Garrett
BE
. 
The role of menthol in cigarettes as a reinforcer of smoking behavior
.
Nicotine Tob Res
2010
;
12
Suppl 2
:
S110
6
.
35.
Trinidad
DR
,
Perez-Stable
EJ
,
Messer
K
,
White
MM
,
Pierce
JP
. 
Menthol cigarettes and smoking cessation among racial/ethnic groups in the United States
.
Addiction
2010
;
105
Suppl 1
:
84
94
.
36.
Stahre
M
,
Okuyemi
KS
,
Joseph
AM
,
Fu
SS
. 
Racial/ethnic differences in menthol cigarette smoking, population quit ratios and utilization of evidence-based tobacco cessation treatments
.
Addiction
2010
;
105
Suppl 1
:
75
83
.
37.
Cruz
TB
,
Wright
LT
,
Crawford
G
. 
The menthol marketing mix: targeted promotions for focus communities in the United States
.
Nicotine Tob Res
2010
;
12
Suppl 2
:
S147
53
.
38.
Gardiner
PS
. 
The African Americanization of menthol cigarette use in the United States
.
Nicotine Tob Res
2004
;
6
Suppl 1
:
S55
65
.
39.
Anderson
SJ
. 
Marketing of menthol cigarettes and consumer perceptions: a review of tobacco industry documents
.
Tob Control
2011
;
20
Suppl 2
:
ii20
8
.
40.
Heck
JD
. 
Smokers of menthol and nonmenthol cigarettes exhibit similar levels of biomarkers of smoke exposure
.
Cancer Epidemiol Biomarkers Prev
2009
;
18
:
622
9
.
41.
Heck
JD
. 
A review and assessment of menthol employed as a cigarette flavoring ingredient
.
Food Chem Toxicol
2010
;
48
Suppl 2
:
S1
38
.
42.
Werley
MS
,
Coggins
CR
,
Lee
PN
. 
Possible effects on smokers of cigarette mentholation: a review of the evidence relating to key research questions
.
Regul Toxicol Pharmacol
2007
;
47
:
189
203
.
43.
Heck
JD
,
Hamm
LA
,
Lauterbach
HJ
. 
The industry menthol report. Menthol cigarettes: no disproportionate impact on public health
. 
2011
.
[cited 2011 Mar 24]
.
Available from:
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/TobaccoProductsScientificAdvisoryCommittee/UCM249320.pdf.
44.
Gardiner
P
,
Clark
PI
. 
Menthol cigarettes: moving toward a broader definition of harm
.
Nicotine Tob Res
2010
;
12
Suppl 2
:
S85
93
.
45.
Yerger
VB
,
McCandless
PM
. 
Menthol sensory qualities and smoking topography: a review of tobacco industry documents
.
Tob Control
2011
;
20
Suppl 2
:
ii37
43
.